Evidence Encourages the use of Topical Analgesics

The trend is toward targeted relief

Today, throughout the pain management community, the shift is toward the use topical analgesics and away from systemic pain relievers. Fueling this trend is evidence-based research linking currently available systemic pain relievers to adverse events. NSAIDs, COX-2 inhibitors, and opioids can effect the gastrointestinal tract, heart, kidneys, and other organs, as well as cognition. Conversely, topical analgesics, such as BioFreeze Pain Reliever, deliver targeted pain relief with low levels of systemic absorption and therefore less risk for systemic toxicity and/or drug interaction. Pain-management clinicians are encouraged to consider and recommend topical analgesics as effective, safer alternatives to systemic medications.

4 oz. gel

3 oz. roll on

4 oz. spray

16 oz. pump

32 oz. pump